Abstract:ID 87555 Poster Board 494 Bioactive compounds sometimes possess unfavorable properties for drug development due to on-target, off-tissue mediated side effects or poor pharmacological properties. Activation of drug targets expressed in tissues not involved in therapeutic responses can limit medical application. One solution is to use analogue(s) or fragments of bioactive drugs that become activated only at sites of interest. Herein we describe the development of fragments of a peptidic GPCR ligand that can react to form a bioactive product upon exposure to a dimerizing agent that stimulates in situ assembly. To enhance specificity, we developed methods for the directed delivery of such a dimerizing agent to cell types of choice. We sought to apply this approach for activation of the parathyroid hormone receptor-1 (PTHR1), which regulates skeletal development and mineral ion homeostasis. The prototypical peptide agonist of PTHR1 (PTH 1-34 ) was separated into two constituent fragments (PTH 1-11 and PTH 12-34 ), each of which possesses little to no biological activity alone. In situ synthesis of conjugates that resemble PTH 1-34 was achieved through peptide template-induced dimerization and click (azide-alkyne) reactions between the fragment peptides PTH 1-11 and PTH 12-34. Dimerization is facilitated through the binding of nanobodies (Nbs) to peptide tags as described below. Nbs are single antigen recognition domains of heavy-chain only antibodies, which exhibit specificity and affinity for biological macromolecules comparable to conventional antibodies. Templated dimerization was achieved by fusing PTH fragments containing click chemistry handles to one of two Nbs that bind to short peptide epitopes. A heterodimeric peptide (HDP), comprised of the two distinct Nb-binding peptide epitopes, was used to bring fusions comprised of Nbs and PTH fragments with complementary click handles, into proximity. HDP-induced co-localization was designed to trigger the click reaction within the cellular medium at high dilution. Gel electrophoresis analysis of the kinetics of the reaction between azide- and alkyne-functionalized Nbs showed that HDP-mediated dimerization accelerated reaction kinetics. In the context of a cell-based assays, PTH fragment-click handle-Nb conjugates were weakly active alone or when added in tandem. The addition of HDP to the tandem mixture resulted in strong activation (via in situ ligand assembly) of PTHR1. We further demonstrate that dimeric peptide-induced in situ assembly can be achieved with cell-type specificity and high efficiency via Nb-based delivery of dimerizing agent. Altogether, this approach entails a new strategy for in situ synthesis of a bioactive agonist from its inactive fragment peptides. These results offer a path towards in situ assembly of bioactive molecules based on targeted delivery of dimerizing agents. These findings, coupled with the modular and programmable nature of our strategy, suggest the possibility of engineering similar approaches for the targeted synthesis of a diverse range of clinically relevant molecules in various in vitro and in vivo settings. This research was supported by the Intramural Research Program of the NIH, The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

RNA-templated chemical synthesis of proapoptotic L- and d-peptides

Dna-Directed Formation of Peptide Bond: A Model Study Toward Dna-Programmed Peptide Ligation

Single-nucleotide-specific PNA-peptide ligation on synthetic and PCR DNA templates

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

Endosomolytic Peptides Enable the Cellular Delivery of Peptide Nucleic Acids

Synthetic peptides: promising modalities for the targeting of disease related nucleic acids

Selective Activation of Peptide‐Thioester Precursors for Templated Native Chemical Ligations

RNA-directed peptide synthesis across a nicked loop

RNA‐Templated Concatenation of Triplet Nucleic‐Acid Probe

Modulating Protein Protein Interactions in Vivo Via Peptide-Lanthanide-Derived Nanoparticles for Hazard-Free Cancer Therapy

Abiotic peptides as carriers of information for the encoding of small-molecule library synthesis

Chemo-ribosomal synthesis of atropisomeric and macrocyclic peptides with embedded quinolines

Walking through the wonder years of artificial DNA: peptide nucleic acid

Synthesis of Novel Protected Nα(ω-Drug) Amino Acid Building Units for Facile Preparation of Anticancer Drug-Conjugates

Activation of PTH1 receptor using chimeric peptide templated in situ click reaction of nanobody conjugates

Unveiling the Promise of Peptide Nucleic Acids as Functional Linkers for Riboglow RNA Imaging Platform

Activatable Protein Nanoparticles for Targeted Delivery of Therapeutic Peptides

The New Salicylaldehyde S,S-Propanedithioacetal Ester Enables N-to-C Sequential Native Chemical Ligation and Ser/Thr Ligation for Chemical Protein Synthesis

Design and Synthesis of Nucleic Acid Nano-environment Interactome-Targeting Small Molecule PROTACs and Their Anticancer Activity

Biomimetic Α-Selective Ribosylation Enables Two-Step Modular Synthesis of Biologically Important ADP-ribosylated Peptides.

Sequence-specific DNA Strand Cleavage by 111In-Labeled Peptide Nucleic Acids.